634.7500 -15.15 (-2.33%)
NSE May 02, 2025 15:31 PM
Volume: 331.5K
 

634.75
-2.33%
Sharekhan
Q2FY2021 was a soft quarter for Strides. The results missed estimates. Revenues grew 11% YoY to Rs 793 crore while the adjusted PAT at Rs 44 crore declined by 9%. Strtides expects a marked improvement in its performance in 2HFY2021 as compared...
Promoters unpledged 2.27% of shares in last quarter. Total pledge stands at 51.98% of promoter holdings
More from Strides Pharma Science Ltd.
Recommended